592 related articles for article (PubMed ID: 19959009)
21. [Tracers in oncology - preclinical and clinical evaluation].
Krause BJ; Schwarzenböck S; Schwaiger M
Nuklearmedizin; 2010; 49 Suppl 1():S41-5. PubMed ID: 21152689
[TBL] [Abstract][Full Text] [Related]
22. ¹⁸F-fluorodeoxyglucose PET/computed tomography for primary brain tumors.
Segtnan EA; Hess S; Grupe P; Høilund-Carlsen PF
PET Clin; 2015 Jan; 10(1):59-73. PubMed ID: 25455880
[TBL] [Abstract][Full Text] [Related]
23. [Functional imaging in brain tumors].
Borbély K
Orv Hetil; 2004 Feb; 145(8):411-23. PubMed ID: 15061026
[TBL] [Abstract][Full Text] [Related]
24. Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine.
Kaschten B; Stevenaert A; Sadzot B; Deprez M; Degueldre C; Del Fiore G; Luxen A; Reznik M
J Nucl Med; 1998 May; 39(5):778-85. PubMed ID: 9591574
[TBL] [Abstract][Full Text] [Related]
25. Clinical applications of PET in brain tumors.
Chen W
J Nucl Med; 2007 Sep; 48(9):1468-81. PubMed ID: 17704239
[TBL] [Abstract][Full Text] [Related]
26. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
Vallabhajosula S
Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
[TBL] [Abstract][Full Text] [Related]
27. Current Radiopharmaceuticals for Positron Emission Tomography of Brain Tumors.
Jung JH; Ahn BC
Brain Tumor Res Treat; 2018 Oct; 6(2):47-53. PubMed ID: 30381916
[TBL] [Abstract][Full Text] [Related]
28. Pioneering and fundamental achievements on the development of positron emission tomography (PET) in oncology.
Fukuda H; Kubota K; Matsuzawa T
Tohoku J Exp Med; 2013 Jul; 230(3):155-69. PubMed ID: 23883588
[TBL] [Abstract][Full Text] [Related]
29. 2-[C-11]thymidine imaging of malignant brain tumors.
Eary JF; Mankoff DA; Spence AM; Berger MS; Olshen A; Link JM; O'Sullivan F; Krohn KA
Cancer Res; 1999 Feb; 59(3):615-21. PubMed ID: 9973209
[TBL] [Abstract][Full Text] [Related]
30. Oncologic PET tracers beyond [(18)F]FDG and the novel quantitative approaches in PET imaging.
Kumar R; Dhanpathi H; Basu S; Rubello D; Fanti S; Alavi A
Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):50-65. PubMed ID: 18235421
[TBL] [Abstract][Full Text] [Related]
31. Non-FDG PET in the practice of oncology.
Caroli P; Nanni C; Rubello D; Alavi A; Fanti S
Indian J Cancer; 2010; 47(2):120-5. PubMed ID: 20448372
[TBL] [Abstract][Full Text] [Related]
32. Clinical interest of integrating positron emission tomography imaging in the workup of 55 children with incidentally diagnosed brain lesions.
Pirotte BJ; Lubansu A; Massager N; Wikler D; Van Bogaert P; Levivier M; Brotchi J; Goldman S
J Neurosurg Pediatr; 2010 May; 5(5):479-85. PubMed ID: 20433262
[TBL] [Abstract][Full Text] [Related]
33. Increased fluorine-18 2-fluoro-2-deoxy-D-glucose (FDG) uptake in childhood CNS tumors is correlated with malignancy grade: a study with FDG positron emission tomography/magnetic resonance imaging coregistration and image fusion.
Borgwardt L; Højgaard L; Carstensen H; Laursen H; Nowak M; Thomsen C; Schmiegelow K
J Clin Oncol; 2005 May; 23(13):3030-7. PubMed ID: 15860860
[TBL] [Abstract][Full Text] [Related]
34. PET imaging for brain tumor diagnostics.
Suchorska B; Tonn JC; Jansen NL
Curr Opin Neurol; 2014 Dec; 27(6):683-8. PubMed ID: 25333605
[TBL] [Abstract][Full Text] [Related]
35. Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.
Chen W; Cloughesy T; Kamdar N; Satyamurthy N; Bergsneider M; Liau L; Mischel P; Czernin J; Phelps ME; Silverman DH
J Nucl Med; 2005 Jun; 46(6):945-52. PubMed ID: 15937304
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of primary brain tumors using 11C-methionine PET with reference to a normal methionine uptake map.
Coope DJ; Cízek J; Eggers C; Vollmar S; Heiss WD; Herholz K
J Nucl Med; 2007 Dec; 48(12):1971-80. PubMed ID: 18006617
[TBL] [Abstract][Full Text] [Related]
37. Brain Tumors: An Update on Clinical PET Research in Gliomas.
Herholz K
Semin Nucl Med; 2017 Jan; 47(1):5-17. PubMed ID: 27987557
[TBL] [Abstract][Full Text] [Related]
38. Brain tumors.
Goldman S; Pirotte BJ
Methods Mol Biol; 2011; 727():291-315. PubMed ID: 21331940
[TBL] [Abstract][Full Text] [Related]
39. FDG PET with contrast-enhanced CT: a critical imaging tool for laryngeal carcinoma.
Chu MM; Kositwattanarerk A; Lee DJ; Makkar JS; Genden EM; Kao J; Packer SH; Som PM; Kostakoglu L
Radiographics; 2010 Sep; 30(5):1353-72. PubMed ID: 20833855
[TBL] [Abstract][Full Text] [Related]
40. Advances in PET imaging of brain tumors: a referring physician's perspective.
Petrirena GJ; Goldman S; Delattre JY
Curr Opin Oncol; 2011 Nov; 23(6):617-23. PubMed ID: 21825989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
